CINECA IRIS Institutional Research Information System

RUBATTO, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 846
EU - Europa 271
AS - Asia 148
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 2
Totale 1.282
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 845
IE - Irlanda 86
IT - Italia 85
SG - Singapore 55
CN - Cina 49
SE - Svezia 48
IN - India 23
DE - Germania 12
NG - Nigeria 10
BE - Belgio 8
KR - Corea 7
JP - Giappone 6
UA - Ucraina 6
EU - Europa 5
FI - Finlandia 5
MY - Malesia 5
RU - Federazione Russa 5
GB - Regno Unito 3
RO - Romania 3
AT - Austria 2
FR - Francia 2
HK - Hong Kong 2
SI - Slovenia 2
BR - Brasile 1
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
GR - Grecia 1
NL - Olanda 1
TR - Turchia 1
Totale 1.282
Salva come PNG Salva come JPEG
Città #
Chandler 310
Dublin 86
Ashburn 52
Nyköping 43
Singapore 38
Princeton 28
Medford 24
Boston 18
Hebei 17
Pune 17
Turin 17
Fairfield 15
New York 12
Milan 11
Abuja 10
Ann Arbor 10
Hangzhou 10
Beijing 9
Brussels 8
Chengdu 7
Seattle 7
Seoul 7
Torino 7
Cambridge 6
Wilmington 6
Woodbridge 5
Chennai 4
Lappeenranta 4
Moscow 4
Mountain View 4
Parma 4
Washington 4
Bari 3
Castiglione Olona 3
Los Angeles 3
Redmond 3
Adrano 2
Arezzo 2
Berlin 2
Bologna 2
Guiyang 2
Houston 2
Hyderabad 2
Kuala Lumpur 2
Ljubljana 2
London 2
L’Aquila 2
Montelupone 2
Norwalk 2
Perugia 2
Pescara 2
Putrajaya 2
San Diego 2
Atlanta 1
Baricella 1
Castel San Pietro Terme 1
Chioggia 1
Clearwater 1
Como 1
Denizli 1
Eitensheim 1
Esslingen am Neckar 1
Falls Church 1
Frankfurt am Main 1
Frederick 1
Galati 1
Helsinki 1
Henderson 1
Kajang 1
Naples 1
Philadelphia 1
Piraeus 1
Provo 1
Québec 1
Redwood City 1
Renens 1
Rimini 1
Rome 1
Santa Clara 1
Santiago 1
Scafati 1
Shenyang 1
Slough 1
Stuttgart 1
Suceava 1
São Paulo 1
Upper Marlboro 1
Vidin 1
Totale 885
Salva come PNG Salva come JPEG
Nome #
Immunotherapy in Xeroderma Pigmentosum: A case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review 75
Immunotherapy in transplanted patients: A special population that can no longer be ignored 68
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era 54
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: Experience from an Italian skin cancer unit 54
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study 53
The Effect of the COVID-19 Lockdown on Melanoma Diagnosis in Italy 52
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome 51
Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden? 51
Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials 51
Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma 49
Prognostic and predictive biomarkers in stage iii melanoma: Current insights and clinical implications 45
Melanoma management during the covid-19 pandemic emergency: A literature review and single-center experience 44
Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit 43
Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome? 43
Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study 42
Misuse, consequences and phototoxic skin-related effects of Rutaceae: a comprehensive literature review 41
Ruta graveolens phytophotodermatìtis 40
Risankizumab shows high efficacy and maintenance in improvement of response until week 52 39
Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population 34
Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers 31
Predictive value of baseline [18f]fdg pet/ct for response to systemic therapy in patients with advanced melanoma 31
Treatment of Advanced Metastatic Melanoma 30
Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis 29
Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study) 28
Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System 28
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19 27
Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study 25
Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy 25
Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review 20
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma 20
Dramatic response of face desmoplastic melanoma after two doses of immunotherapy 18
Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience 18
Nonmelanoma skin cancer arising on tattoos 17
Perspectives of immunotherapy in non-melanoma skin cancers 15
Regression of human papillomavirus-associated high-grade vaginal intraepithelial neoplasia after switching from ustekinumab to risankizumab in a psoriasis patient 12
Liver metastases and immunotherapy: A barrier to response for metastatic melanoma 12
Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: A single-centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course 9
Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer 5
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup 4
The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy-Multicenter Italian-Polish Report 3
A retrospective observational study on cutaneous adverse events induced by immune checkpoint inhibitors 3
Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies 3
Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice? 2
Advanced Cutaneous Squamous Cell Carcinoma: Italian Multicentric Retrospective Analysis of Patient Profiles and Therapeutic Approaches 2
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 1
Totale 1.347
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.278
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 2 3 0 0 0 2
2021/2022339 36 7 8 9 63 19 13 10 13 8 55 98
2022/2023668 57 87 10 63 69 137 32 56 71 16 44 26
2023/2024333 36 66 19 26 18 81 2 15 1 24 9 36
Totale 1.347